4//SEC Filing
McMahon Gerald PhD 4
Accession 0001179110-18-006035
CIK 0000744218other
Filed
May 1, 8:00 PM ET
Accepted
May 2, 7:16 AM ET
Size
5.9 KB
Accession
0001179110-18-006035
Insider Transaction Report
Form 4
McMahon Gerald PhD
Director
Transactions
- Tax Payment
Common Stock, par value $0.001 per share
2018-05-01$0.74/sh−2,813$2,082→ 200,549 total
Footnotes (2)
- [F1]On November 28, 2016, in connection with the Reporting Person's employment separation agreement with Kolltan Pharmaceuticals, Inc., Reporting Person entered into a severance agreement (the "Severance Agreement") with Celldex Therapeutics, Inc. ("Issuer") whereby Issuer agreed to pay Reporting Person 267,356 shares of its common stock, par value $0.001 per share ("Common Stock") less required tax and other withholdings (the "Withholdings".) The Reporting Person previously reported ownership of such 267,356 shares on his Form 3 filed with the Securities and Exchange Commission on December 15, 2016. The shares, less Withholdings, are issuable to Reporting Person in equal installments through December 2018.
- [F2]Pursuant to the Severance Agreement, on May 1, 2018, the Issuer issued 5,541 shares of its Common Stock to the Reporting Person. This Form 4 reflects the disposition to the Issuer of 2,813 shares of its Common Stock to satisfy required Withholdings in connection with such issuance of Common Stock to the Reporting Person.
Documents
Issuer
Celldex Therapeutics, Inc.
CIK 0000744218
Entity typeother
Related Parties
1- filerCIK 0001290747
Filing Metadata
- Form type
- 4
- Filed
- May 1, 8:00 PM ET
- Accepted
- May 2, 7:16 AM ET
- Size
- 5.9 KB